毒素如何应对功能恶化和口服有毒吸收剂在pH控制释放囊中的功能恶化
Wen-Sheng Liu1,2,3,4,5, Shih-Shin Liang6,7, Mei-Mei Cheng8
1Division of Nephrology, Department of Medicine, Taipei City Hospital, Taipei, Taiwan.
口服活性炭 (AC-134) 可能通过减少尿素毒素,如阿克罗莱因,改善慢性病 (CKD) 患者的功能. 一些患者表现出改善的膜过率 (GFR) 和血红蛋白水平.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 毒理学 毒理学 毒理学
- 胃肠病学 胃肠病学
背景情况:
- 慢性病 (CKD) 的患病率正在全球范围内上升.
- 尿液中毒素 (硫酸氨基,p-cresol,acrolein,PFAS) 和炎症标志物 (IL-6,TNF-alpha) 与CKD进展有关.
- 口服毒素吸附剂为管理CKD提供了潜在的治疗途径.
研究的目的:
- 评估口服活性炭 (AC-134) 在改善功能和减少CKD患者尿路毒素方面的疗效.
- 评估AC-134对血红蛋白水平,炎症标志物和特定毒素 (PFAS,acrolein) 的影响.
- 探索基线患者特征,毒素水平和治疗反应之间的相关性.
主要方法:
- 一项前性研究涉及81名CKD患者,他们接受了AC-134囊治疗一个月.
- 这些测量包括功能 (GFR),血红蛋白,炎症标志物,PFAS (PFOA,PFOS,PFNA) 和acrolein.
- 根据CKD阶段 (3,4,5) 和反应 (基于GFR改善的响应者与非响应者) 来分层患者.
主要成果:
- 治疗AC-134导致膜过率 (GFR) 显著改善,并降低了烯蛋白水平.
- 与第三阶段相比,CKD第4阶段和第5阶段的患者表现出较高的尿素毒素 (IS,PCS,IL-6,TNF) 和较低的血红蛋白和PFAS.
- 受访者表现出较高的基线阿克罗莱因和PFOA,阿克罗莱因的减少更大,这表明改善了消化功能和与eGFR的潜在联系.
- 只有在干预后的CKD第3阶段组中,血红蛋白显著增加.
结论:
- 口服AC-134在改善GFR和降低阿克罗林方面表现出潜在的潜力,作为CKD中功能变化的潜在指标.
- 较高的PFOA和较低的acrolein水平可能与改善的eGFR有关.
- 需要进行更长的随访期的进一步研究来证实这些发现,并探索蛋白尿症的关联.
更多相关视频
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
07:11Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
相关概念视频
Drug Elimination by Renal Route: Tubular Reabsorption
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Renal Drug Excretion: Tubular Reabsorption
Renal Drug Excretion: Tubular Secretion
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Renal Drug Excretion: Overview
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
